A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
Clinical trial NCT05435677 · COMPLETED
Trial details
- NCT number
- NCT05435677
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2023-04-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.